SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Vitalhub Corp. (VHIBF) trades at a trailing P/E of 59.0, forward P/E of 20.4. Trailing earnings yield is 1.69%, forward earnings yield 4.89%. PEG 0.85 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 59.0).
- Forward P/E 20.4 (down from trailing 59.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.85 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.69% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.89% as earnings recover.
Overall SharesGrow Score: 72/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VHIBF
Valuation Multiples
P/E (TTM)59.0
Forward P/E20.4
PEG Ratio0.85
Forward PEG0.11
P/B Ratio0.00
P/S Ratio3.27
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.10
Forward EPS (Est.)$0.29
Book Value / Share$0.00
Revenue / Share$1.81
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.69%
Forward Earnings Yield4.89%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.90 |
$488.14K |
$-1.41M |
-288.9% |
| 2017 |
$-0.49 |
$1.15M |
$-2.38M |
-207.7% |
| 2018 |
$-0.07 |
$9.11M |
$-862.43K |
-9.5% |
| 2019 |
$-0.04 |
$10.23M |
$-625.53K |
-6.1% |
| 2020 |
$-0.08 |
$13.79M |
$-2.17M |
-15.7% |
| 2021 |
$-0.05 |
$24.66M |
$-1.95M |
-7.9% |
| 2022 |
$0.03 |
$39.97M |
$1.21M |
3% |
| 2023 |
$0.10 |
$52.51M |
$4.55M |
8.7% |
| 2024 |
$0.06 |
$68.59M |
$3M |
4.4% |
| 2025 |
$0.10 |
$108.88M |
$6.11M |
5.6% |
